Literature DB >> 20413618

An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing.

Natalia N Singh1, Katrin Hollinger, Dhruva Bhattacharya, Ravindra N Singh.   

Abstract

Here we report a novel finding of an antisense oligonucleotide (ASO) microwalk in which we examined the position-specific role of intronic residues downstream from the 5' splice site (5' ss) of SMN2 exon 7, skipping of which is associated with spinal muscular atrophy (SMA), a leading genetic cause of infant mortality. Our results revealed the inhibitory role of a cytosine residue at the 10th intronic position ((10)C), which is neither conserved nor associated with any known splicing motif. Significance of (10)C emerged from the splicing pattern of SMN2 exon 7 in presence of a 14-mer ASO (L14) that sequestered two adjacent hnRNP A1 motifs downstream from (10)C and yet promoted SMN2 exon 7 skipping. Another 14-mer ASO (F14) that sequestered both, (10)C and adjacent hnRNP A1 motifs, led to a strong stimulation of SMN2 exon 7 inclusion. The inhibitory role of (10)C was found to be tightly linked to its unpaired status and specific positioning immediately upstream of a RNA:RNA helix formed between the targeting ASO and its intronic target. Employing a heterologous context as well as changed contexts of SMN2 intron 7, we show that the inhibitory effect of unpaired (10)C is dependent upon a long-distance interaction involving downstream intronic sequences. Our report furnishes one of the rare examples in which an ASO-based approach could be applied to unravel the critical role of an intronic position that may not belong to a linear motif and yet play significant role through long-distance interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413618      PMCID: PMC2874169          DOI: 10.1261/rna.2154310

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  46 in total

Review 1.  The spliceosome: design principles of a dynamic RNP machine.

Authors:  Markus C Wahl; Cindy L Will; Reinhard Lührmann
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 2.  Therapeutic potential of splice-switching oligonucleotides.

Authors:  John Bauman; Natee Jearawiriyapaisarn; Ryszard Kole
Journal:  Oligonucleotides       Date:  2009-03

3.  Conserved RNA secondary structures promote alternative splicing.

Authors:  Peter J Shepard; Klemens J Hertel
Journal:  RNA       Date:  2008-06-25       Impact factor: 4.942

Review 4.  Splicing regulation: from a parts list of regulatory elements to an integrated splicing code.

Authors:  Zefeng Wang; Christopher B Burge
Journal:  RNA       Date:  2008-03-27       Impact factor: 4.942

Review 5.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

6.  Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.

Authors:  Jason H Williams; Rebecca C Schray; Carlyn A Patterson; Semira O Ayitey; Melanie K Tallent; Gordon J Lutz
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

7.  Dynamic regulation of alternative splicing by silencers that modulate 5' splice site competition.

Authors:  Yang Yu; Patricia A Maroney; John A Denker; Xiang H-F Zhang; Olexandr Dybkov; Reinhard Lührmann; Eckhard Jankowsky; Lawrence A Chasin; Timothy W Nilsen
Journal:  Cell       Date:  2008-12-26       Impact factor: 41.582

8.  The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing.

Authors:  M Bryan Warf; Julien V Diegel; Peter H von Hippel; J Andrew Berglund
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-26       Impact factor: 11.205

9.  Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.

Authors:  Yimin Hua; Timothy A Vickers; Hazeem L Okunola; C Frank Bennett; Adrian R Krainer
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

Review 10.  RNA and disease.

Authors:  Thomas A Cooper; Lili Wan; Gideon Dreyfuss
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

View more
  33 in total

Review 1.  Spinal muscular atrophy: an update on therapeutic progress.

Authors:  Joonbae Seo; Matthew D Howell; Natalia N Singh; Ravindra N Singh
Journal:  Biochim Biophys Acta       Date:  2013-08-27

2.  Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions.

Authors:  Natalia N Singh; Brian M Lee; Ravindra N Singh
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

3.  TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy.

Authors:  Natalia N Singh; Joonbae Seo; Eric W Ottesen; Maria Shishimorova; Dhruva Bhattacharya; Ravindra N Singh
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

Review 4.  A novel role of U1 snRNP: Splice site selection from a distance.

Authors:  Ravindra N Singh; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-04-28       Impact factor: 4.490

Review 5.  Advances in therapeutic development for spinal muscular atrophy.

Authors:  Matthew D Howell; Natalia N Singh; Ravindra N Singh
Journal:  Future Med Chem       Date:  2014-06       Impact factor: 3.808

Review 6.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

Review 7.  How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy.

Authors:  N N Singh; M D Howell; E J Androphy; R N Singh
Journal:  Gene Ther       Date:  2017-05-09       Impact factor: 5.250

Review 8.  A survey of transcripts generated by spinal muscular atrophy genes.

Authors:  Natalia N Singh; Eric W Ottesen; Ravindra N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-05-06       Impact factor: 4.490

Review 9.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

Review 10.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.